Loading
companiesCompany
FILO (French Innovative Leukemia Organisation)
aka French Innovative Leukemia Organisation, FILO
FILO is the French cooperative group for leukaemia trials, with its registered office in the haematology department of the Tours university hospital; in OnCo it leads a phase 2 trial of eltrombopag in older patients with acute myeloid leukaemia.
Overview
The French Innovative Leukemia Organisation (FILO) is a French leukaemia cooperative group whose registered office is at the CHU Bretonneau, Centre Henry Kaplan, cellular haematology department, 2 boulevard Tonnellé, Tours (filo-leucemie.org). No founding year is stated on the pages read. ClinicalTrials.gov names it lead sponsor (OTHER class, with Novartis as collaborator) of NCT03603795 (EPAG2015, phase 2, eltrombopag in elderly patients with acute myeloid leukaemia), the trial recorded in OnCo. It has no products of its own.
Similar pages
not linked directly; found by shared links- CompanyALFA (Acute Leukemia French Association)
Shares Acute myeloid leukaemia and the tag cooperative-group.
- PersonRichard M. Stone
Shares Acute myeloid leukaemia and the tag cooperative-group.
- TreatmentEltrombopag
Shares Study Impact on Outcome of Eltrombopag in Elderly Patients with Acute Myeloid Leukemia Receiving Induction Chemotherapy, Acute myeloid leukaemia.